CD8A and neoplasm: In POLE-mutant EC, an increased antitumor response by peritumoral and tumor-infiltrating CD8+ lymphocytes has been reported, most probably because the mutated DNA fragments act as neo-antigens that elicit a strong immune response [24–28].